Rationale: Heart valves develop from precursor structures called cardiac cushions, an endothelial-lined cardiac jelly that resides in the inner side of the heart tube. The cushions are then invaded by cells from different sources, undergo a series of complicated and poorly understood remodeling processes, and give rise to valves. Disruption of the fibroblast growth factor (FGF) signaling axis impairs morphogenesis of the outflow tract (OFT). Yet, whether FGF signaling regulates OFT valve formation is unknown.
C ongenital valve defects occur in 2% to 3% of the population. Cardiac valves developed from cardiac cushions through a series of complicated and poorly defined processes. At early stages, the cardiac cushions are composed of extracellular matrix lined by endothelial cells. The cushions are invaded by endothelial-derived mesenchymal cells after completing the endothelial-mesenchymal transition (EMT) and neural crest cells (NCCs) from pharyngeal arches. 1 The cushions subsequently undergo a series of remodeling processes. A portion of the proximal cushion undergoes remodeling and forms valve primordia and their supporting apparatus. The valve primordia are then gradually transformed from primary bulbous swollen cushions into thinly tapered valve leaflets. 1 Although cushion formation has been extensively studied, how valve primordia are defined and how valve remodeling is regulated remain unclear. It has been proposed that proximal outflow tract (OFT) myocardial cells receive inductive signals and migrate into the cushion. This process, termed as myocardialization, 2 subsequently induces surrounding mesenchymal cells to undergo muscle differentiation. These newly differentiated myocardial cells further induce their adjacent mesenchymal cells to differentiate until the entire mesenchymal structure is muscularized. Although required for OFT septation, 2 whether this process is required for valve formation is unclear.
The fibroblast growth factor (FGF) signaling axis has been shown to play important roles in OFT cushion formation. Yet, its role in OFT valve formation remains to be characterized. The FGF family consists of 18 receptorbinding members that regulate a broad spectrum of cellular activities, 3 and play important roles in heart development. 4 Among them, FGF4 has been shown to regulate valve precursor cell proliferation and differentiation, [5] [6] [7] and FGF8 contributes to OFT valve morphogenesis. 8, 9 FGF elicits its regulatory activities via activating FGF receptor (FGFR) tyrosine kinases encoded by 4 highly homologous genes. FGFR substrate (FRS)2␣ is a broadly expressed adaptor protein that is required for the FGF to activate mitogen activated protein (MAP) and PI3K pathways, the 2 major pathways in the FGF signaling cascade. 10 -12 Frs2␣-null embryos die between embryonic day (E)7.0 to E7.5. 13 Ablation of Frs2␣, or double ablation of Fgfr1/ Fgfr2, in heart progenitor cells disrupts endocardial EMT and NCC deployment to the OFT, resulting in OFT alignment and septation defects. 14 Ablation of Fgf8 also leads to OFT alignment and septation defects. 9 Gain-offunction and dominant-negative mutations of SHP2 that directly bind to FRS2␣ and mediate FGF signaling to the MAP kinase (MAPK) pathway causes enlarged valves in Noonan syndrome and LEOPARD syndrome patients, respectively. 15, 16 In this report, we demonstrated that ablation of Frs2␣, or double ablation of Fgfr1/Fgfr2, in heart progenitor cells led to enlarged OFT valves and bicuspid aortic valves (BAV). FGF regulated Bmp4 expression in the myocardium via activator protein (AP)1 transcription factor binding sites located upstream of the Bmp4 coding sequence. Disrupting FGF signaling diminished Bmp4 expression in the OFT myocardium and reduced smooth muscle (SM) differentiation of cushion NCCs, thus leaving excessive undifferentiated NCC-derived mesenchymal cells within valve primordia. Treating in vitro cultured heart explants with BMP4 partially rescued the defects. The results demonstrate a novel role of NCC differentiation orchestrated by the FGF-BMP signaling axis during OFT valve formation.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
All animals were housed in the Program for Animal Resources of the Institute of Biosciences and Technology and were handled in accordance with the principles and procedures of the Guide for the Care and Use of Laboratory Animals. All experimental procedures were approved by the Institutional Animal Care and Use Committee.
Results

Disruption of FGF Signaling Leads to Enlarged OFT Valves
Disruption of FGF signaling in mouse second heart field (SHF) progenitors compromises OFT cushion formation and results in OFT alignment and septation defects. 9, 14 Because OFT cushions also give rise to both pulmonary and aortic valves, we then investigated whether ablating FGF signaling also affected OFT valve development. Hematoxylin/eosin (H&E) staining of E14.5 embryo sections revealed that Fgfr1 and Fgfr2 double conditional ablations in cardiac progenitor cells with Nkx2.5 Cre (Fgfr1/r2 cn/Nkx ) led to enlarged OFT valves ( Figure 1A ). Individual ablation of Fgfr1 or Fgfr2 failed to cause such defects (data not shown), suggesting redundant activities of the 2 FGFRs in regulating OFT valve development. Because FRS2␣ is the major adaptor protein linking the FGFR to MAP kinase and PI3K/AKT pathways, we then ablated Frs2␣ alleles in the same domain with Nkx2.5 Cre (Frs2␣ cn/Nkx ) or in the SHF with Mef2C Cre (Frs2␣ cn/Mef ). Similar to Fgfr1/r2 cn/Nkx , both Frs2␣ cn/Nkx and Frs2␣ cn/Mef embryos exhibited enlarged OFT valves ( Figure  1A ). The phenotype remained obvious in neonatal hearts (Online Figure I ). The average diameters of pulmonary and aortic valves were 70Ϯ10 m and 62Ϯ11 m in E14.5 control embryos and 103Ϯ26 m and 99Ϯ29 m in Frs2␣ cn/Nkx embryos, respectively ( Figure 1B ). Approximately 20% of Frs2␣ cn/Nkx embryos had BAVs ( Figure 1C ). All valve defects were associated with OFT septation or alignment defects, indicating that OFT cushion remodeling was affected. No apparent defects were found in mitral valves and tricuspid valves ( Figure 1D ). Cell fate mapping experiments showed that atrioventricular valves were only composed of endothelial lineage cells, whereas OFT valves had both endothelium-and NCC-derived cells (Online Figure II) , suggesting that the defects were likely associated with NCC-derived mesenchymal cells.
Defects in OFT Cushion Cell Recruitment, Proliferation, and Apoptosis Are Not Causal Factors for Enlarged Valves in Frs2␣ cn OFT
Both Frs2␣ cn/Nkx and Frs2␣ cn/Mef embryos had enlarged OFT valves ( Figure 1A ). Yet, only Frs2␣ cn/Nkx embryos show reduced endothelial and NCC contributions to OFT cushions and have small OFT cushions. 14 Thus, the valve defect likely did not result from cushion insufficient recruitment of endothelium-and NCC-derived cells into OFT cushions. Because the enlarged Frs2␣ cn OFT valves had more mesenchymal cells at E14.5 day, bromodeoxyuridine labeling was used to determine whether mutant cushions had increased cell proliferation activities. Both mesenchymal and myocardial cells in Frs2␣ cn/Nkx OFT cushions actually had reduced proliferation at E10.5 and E12.5 ( Figure 1E ), which was consistent with our previous report. 14 This suggests that enlarged valves are not caused by proliferation defects.
Non-standard Abbreviations and Acronyms
To test whether the valve enlargement was caused by apoptosis defects, TUNEL assays were used to assess cushion cell apoptosis at E13.5. Compared with control Frs2␣ f/f OFT cushions, apoptotic cell numbers in Frs2␣ cn/Nkx OFT cushions were significantly reduced (Figure 2A and 2B). Consistently, Fgfr1/r2 cn/Nkx OFT cushions also exhibited reduced apoptosis at E13.5 ( Figure 2C ), suggesting that the FGF might be involved in regulating OFT cushion cell apoptosis. Surprisingly, most apoptotic cells were not located at the valve primordia. Instead, they were located beneath the valve primordia, suggesting that enlarged valves were not directly caused by reduced apoptosis. Moreover, Frs2␣ cn/Mef OFT that did not exhibit decreased apoptosis in the cushion ( Figure 2C ), nevertheless, still had enlarged OFT valves ( Figure 1A ), further indicating that OFT valve hyperplasia was not caused by defective apoptosis. Consistent with previous findings in chicken models, 17 cell lineage tracing revealed that only NCC-, but not endocardium-, derived cushion mesenchymal cells underwent apoptosis (Online Figure III ).
Ablation of Frs2␣ Causes Defects in Cushion Myocardialization and Smooth Muscle Differentiation, Leaving Excessive Undifferentiated Mesenchyme Within the OFT Valve Primordia
Unlike wild-type cells that were round, Frs2␣ cn/Nkx OFT valve cells were spindle-like ( Figure 1A , insets), suggesting differentiation defects. We then investigated whether aberrant cushion cell differentiation caused the valve remodeling defects. During this stage, proximal OFT myocardial cells, which express SM ␣-actin (SMA) and sarcomeric myosin, invade the cushion and induce adjacent mesenchymal cells to undergo SM differentiation. 18 -20 Immunostaining with anti-SMA antibodies revealed that at E12.5, the SMA-positive myocardial cells protruded into proximal OFT cushions of wild-type embryos; some cells in the cushion also expressed low level SMA ( Figure 3A , a). In Frs2␣ cn/Nkx embryos, however, the myocardial cells failed to extend into the cushion, and SMA expressing cushion mesenchymal cells was reduced ( Figure 3A , b), indicating defects in both myocardial cell invasion and mesenchymal cell differentiation. At E13.5, increased SMA-positive cells appeared in control OFT cushions, which separated OFT cushions into 2 parts and, thus, defined the valve primordia ( Figure 3A , c). However, the SMA-positive cells in Frs2␣ cn/Nkx OFT cushions were reduced and failed to separate valve primordia from the rest of the cushion, leaving excessive mesenchymal cells within the valve ( Figure 3A, d) . At E14.5, myocardialization and SM differentiation of the proximal outlet septum were almost completed in control cushions; the valve was sculpted, and the aorta was separated from the right ventricle by muscular tissues (Figure 3A , e). In contrast, the outlet septum in Frs2␣ cn/Nkx remained unmuscularized, and the valve still remained bulbous and swollen ( Figure 3A , f). Consistently, similar defects were found in Fgfr1/r2 cn/Nkx and Frs2␣ cn/Mef embryos ( Figure 3B and 3C), further confirming the role of FGF signaling in this process.
Immunostaining with anti-sarcomeric myosin MF20 antibody was carried out to further dissect whether the unmuscularized OFT cushions were caused by defective myocardialization or SM differentiation. In control OFT, the myocardial cells next to cushions were elongated and had lamellipodia extending into the cushion mesenchyme ( Figure 3D, a) . In contrast, Frs2␣ cn/Nkx OFT myocardial cells were round and almost had no lamellipodia extending into the cushion ( Figure 3D, b ), suggesting compromised inward migration of OFT myocardial cells. To confirm this, cells from E13.5 proximal OFTs were isolated for Transwell migration assays, and the myocardial cells that migrated through the membrane were identified by sarco-meric myosin expression. It was apparent that Frs2␣ cn/Nkx OFTs had fewer cells migrating through the membrane than controls ( Figure 3E ), indicating that FRS2␣-mediated signals promoted myocardial cell migration in a cell autonomous manner. Focal adhesion kinase (FAK) and Vangl2 mediated noncanonical Wnt signaling pathways are involved in regulating OFT myocardium migration. 18, 21 However, expressions of FAK, Rock1, Vangl2, and Wnt11 were not changed in E12.5 Frs2␣ cn/Nkx OFT ( Figure 3F ), suggesting that the FGF regulated OFT myocardium migration through other pathways.
FRS2␣-Mediated Signals Are Required for Regulating SM Differentiation of Cushion Mesenchymal Cells in the OFT
The OFT cushion mesenchyme mainly consists of both endocardium-and NCC-derived cells. To determine how FRS2␣-mediated signals regulated cushion cell differentiation and the origin of cushion muscular cells, cell fate mapping was carried out with ROSA26 reporter mice 22 and Tie2 cre driver that was expressed in the endocardium 23 or Ap2␣ cre that was expressed in NCCs. 24 Immunostaining revealed that most mesenchymal cells in proximal OFT cushions were labeled by Ap2␣ cre , but not Tie2 cre , suggestive NCC-origin of the cells. These NCC-derived cells were SMA-positive and MF20-negative ( Figure 4A , a and b), whereas endothelial-derived cells were both SMA and MF20 negative ( Figure 4A , c and d), indicating that NCCbut not endothelial-derived cells in the OFT cushions underwent SM differentiation. All MF-20 -positive cells located at the junction of the OFT myocardium and cushion were ␤-galactosidase (␤-gal) negative in both Tie2 cre -ROSA26 and Ap2␣ cre -ROSA26 mice, suggesting that these cells were neither from the endothelium nor from NCCs, but from the myocardium ( Figure 4A, b and d) . Double staining of ␤-gal and SMA of E12.5 Nkx2.5 Cre - Frs2␣ flox/W -ROSA26 embryos revealed that all SMApositive OFT cushion mesenchymal cells were ␤-gal negative (Figure 4B, a) . Because Nkx 2.5Cre is expressed in both OFT myocardial and endocardial cells, the results confirmed that these SMA-positive mesenchymal cells were neither myocardial nor endocardial derived. Furthermore, because most proximal OFT cushion mesenchymal cells were NCC origin, these ␤-gal-negative and SMApositive cells were most likely derived from NCCs. This population of cells were severely reduced in Nkx2.5 Cre -Frs2␣ f/f -ROSA26 OFT cushions ( Figure 4B, b) , indicating that NCC differentiation was disrupted in mutant cushions. Furthermore, ␤-gal and SMA double negative cells in OFT valves were increased from 17.1%Ϯ5 in Nkx2.5 Cre -Frs2␣ f/w -ROSA26 embryos to 26.7%Ϯ10 in Nkx2.5 Cre -Frs2␣ f/f -ROSA26 embryos at E14.5 ( Figure 4C ), suggesting that more undifferentiated NCCs were left in mutant than in control valve primordia. Because moderate caspase-3 activity is required for stem cell differentiation, [25] [26] [27] we subsequently investigated whether caspase-3 activation levels underlie cushion mesenchymal differentiation and apoptosis. Double immunostaining revealed that wild-type OFT cushions had many mesenchymal cells exhibiting moderate cleaved caspase-3 and SMA staining at E13.5 ( Figure 5A , a, green arrows). Frs2␣ cn/Nkx OFT cushions had reduced caspase-3 positive (strongly and moderately) and SMA-positive cells ( Figure 5A) ; Frs2␣ cn/Mef OFT cushions only had reduced moderate caspase-3 and SMA double positive cells ( Figure 5B ), suggesting that apoptotic and differentiated OFT cushion cells are different subpopulations. To confirm that caspase-3 activity played a key role in cushion cell differentiation, ex vivo cultured E12.5 embryonic hearts were treated with H 2 O 2 to induce caspase-3 activation. As expected, H 2 O 2 treatment induced caspase-3 activation at both high and moderate levels and SMA expression ( Figure 5C ). More importantly, increased SMA expression was found in cells exhibiting moderate caspase-3 activities. Real-time RT-PCR analyses also revealed that SMA expression was increased by H 2 O 2 treatments ( Figure 5D ). Consistently, inhibition of caspase-3 significantly suppressed expression of SMA in NCCs isolated from pharyngeal arches 1 and 2 of E10.5 embryos, as revealed by both immunostaining and real-time RT-PCR analyses ( Figure 5E ). The results further demonstrated that appearance of moderate caspase-3 activity induced OFT cushion cells to differentiate.
The BMP4 Pathway Mediates FGF Signals in Regulating OFT Cushion Cell Differentiation
Because both Nkx2.5 cre and Mef2c cre were not expressed in NCCs, FRS2␣-mediated signals in regulating NCCderived cushion mesenchymal differentiation must be noncell-autonomous and mediated by other signaling pathways. Furthermore, ablation of Frs2␣ in endothelial cells with Tie2 cre did not cause apparent defects, 14 therefore, the mediating signals likely were derived from the OFT myocardium. BMP4 has been shown to control NCC apoptosis 28 ; ablation of Bmp4 also leads to valve hyperplasia. 29 Because Bmp4 expression in the SHF is regulated by FRS2␣-mediated signaling pathways, 14 we then tested whether BMP4 was the downstream pathway that mediated FGF signals in regulating OFT cushion remodeling. Whole-mount in situ hybridization demonstrated that Bmp4 expression was reduced in the Frs2␣ cn/Nkx OFT myocardium at E12.5 ( Figure 6A ). Consistently, phosphorylation of Smad1/5/8, downstream targets of the BMP receptor, was dramatically reduced in Frs2␣ cn/Nkx cushion mesenchymal cells ( Figure 6A ). Ablation of Bmp4 with Mef2c cre also reduced apoptosis, expression of SMA, and activation of caspase-3 in OFT cushion mesenchymal cells ( Figure 6B ). Together, it is suggested that BMP4 is the downstream mediator of FGF for regulating OFT cushion remodeling. To test this possibility, E12.5 hearts were cultured in the presence or absence of BMP4 overnight. Both immunostaining and real-time RT-PCR analyses revealed that BMP4 increased SMA expression in Frs2␣ cn/Nkx OFT ( Figure 6C and 6D) suggesting that BMP4 treatment rescued the defects. Ablation of one Bmp4 allele in Frs2␣ cn/Mef embryos increased the penetrance of valve hyperplasia from 38% to 58% ( Figure 6E ), further suggest- ing that BMP4 mediated FGF signaling in regulating OFT cushion remodeling.
To determine whether Bmp4 expression was regulated by the FGF, in vitro cultured hearts were treated with FGF2, and the Bmp4 expression was assessed with realtime RT-PCR. The results demonstrated that treating the heart with FGF2 significantly increased Bmp4 expression ( Figure 7A ). As a main downstream pathway of FRS2␣, the MAP kinase cascade activates AP1 transcription activity by inducing c-Jun and c-Fos phosphorylation. Immunostaining revealed that c-Jun nuclear localization was reduced in the Frs2␣ cn/Nkx OFT myocardium ( Figure 7B) , indicating compromised c-Jun activation. The upstream noncoding sequence of the Bmp4 allele has 2 candidate AP1 binding sites that potentially can be regulated by FGF signals. Thus, the 3.6 Kb upstream noncoding sequence of the Bmp4 allele was cloned into a luciferase reporter plasmid. Luciferase activity analyses revealed that FGF2 promoted expression of the reporter; deletion of the AP1 binding sites diminished the response ( Figure 7C ). Furthermore, in vivo chromatin immunoprecipitation assays demonstrated that interaction of c-Jun and the proximal, but not the distal, AP1 binding site was reduced in mutant OFTs ( Figure 7D ). Together, the data suggest that the FGF signaling axis in the OFT myocardium regulates Bmp4 expression via activation of AP1 to control cushion NCC differentiation during OFT cushion remodeling.
Discussion
In this report, we demonstrated that FRS2␣-mediated signaling in the myocardium regulated OFT cushion remodeling and defined valve primordia via BMP4. Ablating this signaling axis disrupted cushion myocardialization and SM differentiation, and caused valve enlargement. The results demonstrate a novel FGF-BMP signaling axis from the OFT myocardium to the cushion mesenchyme regulating OFT cushion NCC differentiation, which plays a key role in OFT valve primordium formation. The findings are rather surprising because previous studies show that ablation of FGF signaling leads to small OFT cushions, which give rise to the OFT valves and septum. 9, 14 We further demonstrated that the FGF promoted NCC differentiation non-cell-autonomously via BMP4. The SM differentiation of cushion mesenchymal cells separated them into 2 populations: one underwent SM differentiation and contributed to OFT septation; the other did not undergo muscle differentiation and contributed to OFT valves (Figure 8 ). At E14.5, only a few undifferentiated NCCs remained in WT valves. In mutant mice, however, the disrupted SM differentiation left many undifferentiated NCC-derived mesenchymal cells in the cushions and caused enlarged valves, even though total cushion mesenchymal cells were reduced (Figure 8 ). In some severe cases that had OFT septation defects, the aortic and pulmonary valve primordia were not separated, resulting in a large fused valve. Although it has been reported that mature OFT valve cells are largely derived from the endocardium 30, 31 the part of OFT cushions that gave rise to valves and the underlying region were mainly comprised of NCC-derived mesenchymal cells at E13.5 (Online Figure II) . These NCC lineage cells then either underwent apoptosis or SM differentiation (Figures 4 and 5) , leaving mainly endothelial lineage cells in OFT valves. The data are consistent with previous findings that no endocardial lineage cells in OFT valves undergo apoptosis and that the endocardial lineage replaces NCCs during late stages of valve formation. 30 Frs2␣ cn/Nkx OFT valves had significantly increased non-Nkx2.5 lineage cells ( Figure 4C ), suggesting that more NCC-lineage contributed to mutant OFT valves. Unlike OFT cushions, AV cushions only had the endocardium lineage mesenchymal cells (Online Figure II) . This likely explains why AV valves were not affected by ablation of FGF signaling.
Mutations in SM ␣-actin are associated with familial BAV defects, 32 implying that defective SM differentiation of NCCs may contribute to BAV. However, although NCC differentiation was disrupted in both Frs2␣ cn/Nkx and Frs2␣ cn/Mef OFT cushions, only Frs2␣ cn/Nkx embryos ex-hibited BAV defects, indicating that BAV defects in Frs2␣ mutants were not caused by disrupted NCC differentiation. Because cushion mesenchymal apoptosis was disrupted in Frs2␣ cn/Nkx , but not Frs2␣ cn/Mef , OFT cushions, it is possible that reduced apoptosis contributed to failure in separating the valve leaflets from each other.
FRS2␣ has 4 GRB2 and 2 SHP2 binding sites. SHP2 is a ubiquitously expressed protein tyrosine phosphatase that plays a central role in the MAP kinase and other signaling pathways. 33, 34 Gain of function of SHP2 enhances MAPK activation and promotes the EMT and mesenchymal cell proliferation; dominant negative SHP2 suppresses MAPK activation and fails to arrest the proliferation of mesenchymal cells at later stages. 35 Thus, a narrow range of MAPK activity is required for embryonic development. Ablation of Frs2␣ in heart progenitor cells reduces MAPK activation in the myocardium. Here, we demonstrated that deletion of Frs2␣ led to reduced AP1 transcription activity, resulting in reduced Bmp4 expression in the myocardium, inhibited cushion NCC differentiation, and caused valve hyperplasia. The results reveal a novel mechanism that FGF signals in the OFT myocardium negatively regulate the valve size through promotion of NCC differentiation. The regulatory mechanism underlying SM differentiation of OFT cushion NCCs remains poorly understood. It has been shown that transient and moderate caspase-3 activities promote stem cell differentiation. 25 Consistently, only those cells with moderate caspase-3 activity in OFT cushions undergo SM differentiation. Ablation of Frs2␣ compromised BMP4 signaling in OFT cushion cells and reduced the population of cells with SMA expression and moderate caspase-3 activity. Therefore, the results suggest that BMP4 is an upstream regulator for caspase-3 activation in OFT cushion NCCs. It remains unanswered why these cushion mesenchymal cells have different caspase-3 activities. One possibility is that differentiated NCCs are insensitive to BMP4 stimulation, and undifferentiated NCCs are BMP sensitive and will undergo apoptosis when they receive sustained BMP4 stimulation. However, further experimentation is needed to test this hypothesis.
In conclusion, we demonstrated a novel FGF-BMP signaling axis between the OFT myocardium and cushion mesenchyme that regulated OFT cushion myocardialization and SM differentiation during cushion remodeling and that the 2 processes play an important role in defining OFT valve primordia. The results shed new light on understanding how perturbation of cell signaling and NCC differentiation lead to congenital heart valve defects.
Novelty and Significance
What Is Known?
• Cardiac valves develop from cardiac cushions located inside the heart tube, and cardiac cushion formation and remodeling are the 2 major processes of cardiac valve formation. • Outflow tract (OFT) cushion mesenchymal cells are derived from endothelial and neural crest cells (NCCs). • Fibroblast growth factor (FGF) signaling regulates contributions of endothelial cells and NCCs to the OFT cushion.
What New Information Does This Article Contribute?
• During cushion remodeling, the cushion mesenchymal myocardialization and smooth muscle differentiation defines the size of valve primordium • The FGF-BMP4 signaling axis regulates migration of cardiomyocytes into OFT cushions and smooth muscle differentiation of cushion NCCs. • Disruption of the FGF-BMP4 axis leads to OFT valve hyperplasia.
Congenital cardiac valve defect is a major birth defect. How cardiac valves develop from cardiac cushions and how the valve primordium is defined are poorly understood. Here, we demonstrated that myocardialization and smooth muscle differentiation of cushion mesenchyme defines the valve primordium. We discovered a novel FGF-BMP4 signaling axis from the OFT myocardium to the cushion mesenchyme, which regulates NCC differentiation in the OFT. We further revealed that FGF signaling promotes BMP4 expression through activation of the AP1 transcription factor. Ablation of this signaling axis disrupted myocardialization and smooth muscle differentiation of the cushion, which left too many undifferentiated NCCs within the valves and, thus, caused OFT valve hyperplasia. We also found that ablation of FGF signaling in the myocardium compromised cushion mesenchymal apoptosis and caused bicuspid aortic valve defect. Collectively, our work provides evidence of how the OFT valve primordium is set apart from the rest of the cushions and provides new insight into valve diseases at the molecular and cellular level.
